Eli Lilly Zepbound, Mounjaro available after shortages, FDA says

[Pelican Press 0]

This is the hidden content, please

• Sign In
• or
• Sign Up

Eli Lilly Zepbound, Mounjaro available after shortages, FDA says

An injection pen of Zepbound, Eli Lilly’s weight loss *****, is displayed in New York City, Dec. 11, 2023.

Brendan McDermid | Reuters

All doses of Eli Lilly’s highly popular weight loss injection Zepbound and diabetes ***** Mounjaro are now available in the U.S., according to an

This is the hidden content, please

• Sign In
• or
• Sign Up

on the Food and ***** Administration’s ***** shortage database on Friday. 

A previous update said some doses of the treatments were still in short supply. Some doses of Mounjaro have been in shortage since as early as 2022, while doses of Zepbound joined the FDA’s shortage list earlier this year following its U.S. approval in November. 

Demand for weight loss and diabetes drugs has trounced supply for months, pushing Eli Lilly and its rival Novo Nordisk to invest billions to ramp up manufacturing. 

The FDA’s update comes one day after Eli Lilly CEO David Ricks

This is the hidden content, please

• Sign In
• or
• Sign Up

that the shortages of Mounjaro and Zepbound would end “very soon.” 

“I think actually today or tomorrow we plan to exit that process,” he told the outlet in an interview. 

A spokesperson for Eli Lilly did not immediately respond to a request for comment on the FDA’s update on Friday. 

All doses of Novo Nordisk’s diabetes injection Ozempic are available in the U.S. as of Friday, according to the FDA’s

This is the hidden content, please

• Sign In
• or
• Sign Up

. Meanwhile, the FDA said some doses of Novo Nordisk’s weight loss ***** Wegovy have limited supply.

This is the hidden content, please

• Sign In
• or
• Sign Up

#Eli #Lilly #Zepbound #Mounjaro #shortages #FDA

This is the hidden content, please

• Sign In
• or
• Sign Up

This is the hidden content, please

• Sign In
• or
• Sign Up